Stocks
Edwards Lifesciences (EW) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 186.8% | 273.8% | 356.9% | 402.5% | 376.3% | ||||
| Changes by years, y/y, % | -84pp | +87pp | -274pp | +46pp | +9.3% | ||||
Edwards Lifesciences. R&D/CAPEX, %
Edwards Lifesciences. R&D/CAPEX, changes, pp
Edwards Lifesciences (EW) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 436.8% | 334.3% | 319.2% | 319.2% | 794.4% | 376.3% | ||
| Changes by years, y/y, % | +12pp | -90pp | -245pp | -245pp | +306pp | |||
| Changes by quarters, q/q, % | +171pp | -102pp | -15pp | 0pp | +475pp | |||
